CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jul 15, 2013 · 10-Q · 45 days after period end · 0001303681-13-000059
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | -$4.71K | -$4.00K | -$104.83K |
| EPS Diluted | $0.00 | -$0.01 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended May 31, 2013 · filed Jul 15, 2013 · 45 d after period end
